We explain an observed spontaneous transition to the high-brightness, in-phase array state of a seven-core ytterbium-doped fiber laser array [IEEE Photonics Technol. Lett. 13, 439 (2001)]. The responsible mechanism is nonlinear refraction, and either in-phase or antiphase array modes can be selected by control of pump intensity. The phenomenon appears to be robust and scalable.
We demonstrate, theoretically and experimentally, a high power/energy 19-core Yb-doped fiber amplifier that operates in its fundamental in-phase mode. The calculated result using an improved coupled mode theory with gain shows that, with a Gaussian beam as seed, the in-phase supermode dominates. Experimentally, we use a Q-switched single-core fiber laser with single transverse mode as seed, and amplify it with a 5.8 m 19-core fiber. The measured near and far fields are close to the in-phase supermode. The measured M2 factor of the amplified beam is 1.5, which is close to the theoretical value. A pulse energy gain of 20 dB is obtained with the amplified pulse energy up to 0.65 mJ at a repetition frequency of 5 kHz. No appreciable stimulated Brillouin scattering is observed at this power level.
We present a kinetic model for Q-switched, cladding-pumped, high-power Yb-doped fiber lasers that are based on the rate equation, in a difference equation form, of ion population and propagation equations for both pumping and signal light. The effects of fiber-laser parameters, such as doping, length, pump power, and repetition rate on pulse characteristics are analyzed. This model is used to analyze the performance of Q-switched multicore fiber lasers and to show the output pulses with enhanced characteristics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.